Salvina Therapeutics AG
History from 17 May 2023
- UID
- CHE-191.062.900
- Legal form
- AG
- Canton
- BL
- Founded
- 17 May 2023
- Amount raised
- not in the SHAB
- Lead investor
- not in the SHAB
- shares
- Vorzugsaktien
Record
SHAB published 23 May 2023 · legal date 17 May 2023
Company formed
Founded 17 May 2023
SHAB HR01-1005751800 ↗SHAB published 8 Aug 2024 · legal date 17 Jul 2024
Capital increase
Not assessedPaid in cash
- Nominal capital
- 100’000 → 316’483.60
- Shares
- 1’000’000 → 3’164’836
- New shares, % of post-step shares
- 68.4% (2’164’836 new)
- Share classes
- 1’000’000 × CHF 0.10 · 2’164’836 × CHF 0.10 Vorzugsaktien
SHAB HR02-1006102553 ↗Aktienkapital neu: CHF 316'483.60 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 316'483.60 [bisher: CHF 100'000.00]. Aktien neu: 1'000'000 Namenaktien zu CHF 0.10 und 2'164'836 Namenaktien zu CHF 0.10 (Vorzugsaktien) [bisher: 1'000'000 vinkulierte Namenaktien zu CHF 0.10].
From the SHAB entry · German original, person names removed · not an official copy · full entry ↗ SHAB published 22 Jan 2026 · legal date 18 Dec 2025
Capital increase
Likely financingPaid in cash
- Nominal capital
- 316’483.60 → 426’373.40
- Shares
- 3’164’836 → 4’263’734
- New shares, % of post-step shares
- 25.8% (1’098’898 new)
- Share classes
- 1’000’000 × CHF 0.10 · 3’263’734 × CHF 0.10 Vorzugsaktien
Aktienkapital neu: CHF 426'373.40 [bisher: CHF 316'483.60]. Liberierung Aktienkapital neu: CHF 426'373.40 [bisher: CHF 316'483.60]. Aktien neu: 1'000'000 vinkulierte Namenaktien zu CHF 0.10 und 3'263'734 vinkulierte Namenaktien zu CHF 0.10 (Vorzugsaktien) [bisher: 2'164'836 Namenaktien zu CHF 0.10 (Vorzugsaktien) und 1'000'000 Namenaktien zu CHF 0.10].
From the SHAB entry · German original, person names removed · not an official copy · full entry ↗ SHAB HR02-1006546795 ↗Classifier score 0.90 · likely-financing threshold 0.60 · not a calibrated probability
Published by 8 Oct 2026